Status and phase
Conditions
Treatments
About
The purpose of this study is to investigate the safety and immunogenicity of three different concentrations of a TBE vaccine will be investigated in healthy children aged 6 to 16 years.
Sex
Ages
Volunteers
Inclusion criteria
Male and female children will be eligible for participation in this study if:
For safety reasons female volunteers capable of bearing children have to fulfill the following inclusion criteria at study start:
Exclusion criteria
Children will be excluded from participation in this study if they:
Volunteers who meet the inclusion / exclusion criteria, but have a febrile illness (body temperature >= 38° C, measured orally) at the scheduled time of vaccination, will not be vaccinated before their body temperature returns to normal.
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal